Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION

(BSX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/17/2020 11/18/2020 11/19/2020 11/20/2020 11/23/2020 Date
35.03(c) 34.26(c) 34.21(c) 33.7(c) 33.33(c) Last
34 678 265 22 512 336 14 816 271 15 402 501 18 823 425 Volume
-7.89% -2.20% -0.15% -1.49% -1.10% Change
More quotes
Financials (USD)
Sales 2020 10 091 M - -
Net income 2020 -4,77 M - -
Net Debt 2020 7 480 M - -
P/E ratio 2020 -761x
Yield 2020 -
Sales 2021 11 799 M - -
Net income 2021 1 519 M - -
Net Debt 2021 5 691 M - -
P/E ratio 2021 31,1x
Yield 2021 -
Capitalization 47 726 M 47 726 M -
EV / Sales 2020 5,47x
EV / Sales 2021 4,53x
Nbr of Employees 36 000
Free-Float 85,1%
More Financials
Company
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (61.1%): products used in cardiology surgeries (42.9% of net sales), cardiac rhythm management (29.6%), peripheral surgeries (21.2%), and other (6.4%); - endodontic surgery (30.8%): equipment used in endoscopy (57.3% of net... 
More about the company
Notations Surperformance© of Boston Scientific Corporation
Trading Rating : Investor Rating :
More Ratings
All news about BOSTON SCIENTIFIC CORPORATION
11/23BOSTON SCIENTIFIC : to Participate in Evercore ISI 2020 Healthcare Conference
PR
11/20INVESTOR ALERT : Kaplan Fox Continues To Investigate Boston Scientific Corporati..
PR
11/18SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investor..
PR
11/18BOSTON SCIENTIFIC CORP : Costs Associated with Exit or Disposal Activities, Othe..
AQ
11/17Walgreens, Boston Scientific fall; Tesla, Paramount rise
AQ
11/17Walgreens, Boston Scientific fall; Tesla, Paramount rise
AQ
11/17BOSTON SCIENTIFIC : Shares Drop 8% After Recall of Aortic Valve System
DJ
11/17BOSTON SCIENTIFIC : Recalling Unused Inventory of LOTUS Edge Aortic Valve System
DJ
11/17BOSTON SCIENTIFIC : Announces LOTUS Edge™ Aortic Valve System Voluntary Re..
PR
11/06Drop in Jobless Rate Shows Healing U.S. Labor Market -- 4th Update
DJ
11/06Drop in Jobless Rate Shows Healing U.S. Labor Market -- 3rd Update
DJ
11/06U.S. Nonfarm Payrolls Up 638K in October, Jobless Rate Falls to 6.9% -- 2nd U..
DJ
11/06U.S. Job Growth Likely Persisted in October
DJ
11/05BOSTON SCIENTIFIC : Announces November 2020 Conference Schedule
PR
11/05BOSTON SCIENTIFIC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
More news
News in other languages on BOSTON SCIENTIFIC CORPORATION
10/27TAGESVORSCHAU : Termine am 28. Oktober 2020
10/23BOSTON SCIENTIFIC CORPORATION : publication des résultats trimestriels
10/23BOSTON SCIENTIFIC CORPORATION : Veröffentlichung des Quartalsergebnisses
07/28TAGESVORSCHAU : Termine am 29. Juli 2020
07/24BOSTON SCIENTIFIC CORPORATION : publication des résultats semestriels
More news
Analyst Recommendations on BOSTON SCIENTIFIC CORPORATION
More recommendations
Chart BOSTON SCIENTIFIC CORPORATION
Duration : Period :
Boston Scientific Corporation Technical Analysis Chart | BSX | US1011371077 | MarketScreener
Technical analysis trends BOSTON SCIENTIFIC CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Average target price 43,54 $
Last Close Price 33,33 $
Spread / Highest target 50,0%
Spread / Average Target 30,6%
Spread / Lowest Target 20,0%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward F. Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Jodi Eddy Chief Information Officer & SVP
Sector and Competitors